Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry

被引:9
作者
Krittayaphong, Rungroj [1 ,2 ]
Winijkul, Arjbordin [2 ]
Methavigul, Komsing [3 ]
Lip, Gregory Y. H. [4 ,5 ,6 ]
机构
[1] Mahidol Univ, Fac Med Siriraj Hosp, Dept Med, Div Cardiol, 2 Wanglang Rd, Bangkok 10700, Thailand
[2] Mahidol Univ, Fac Med Siriraj Hosp, Dept Med, Div Cardiol, Bangkok, Thailand
[3] Cent Chest Inst Thailand, Dept Cardiol, Nonthaburi, Thailand
[4] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[5] Liverpool Heart & Chest Hosp, Liverpool, England
[6] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 03期
关键词
ABC pathway; death; ischemic stroke; major bleeding; systolic blood pressure; time in therapeutic range; STROKE PREVENTION; ASIAN PATIENTS; ABC PATHWAY; DEFINITIONS; TRIALS;
D O I
10.1161/JAHA.122.028463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe aimed to determine the effect of integrating Atrial Fibrillation Better Care pathway compliance in relation to achievement of systolic blood pressure (SBP) targets and good control of time in therapeutic range (TTR) on clinical outcomes in patients with atrial fibrillation. Methods and ResultsWe prospectively enrolled patients with nonvalvular atrial fibrillation from 27 hospitals in Thailand. All clinical outcomes were recorded. Main outcomes were the composite of all-cause death or ischemic stroke/systemic embolism (SSE), as well as secondary outcomes of all-cause death, SSE, major bleeding, intracranial hemorrhage, and heart failure. An SBP of 120 to 140 mm Hg was considered good blood pressure control. Target TTR was a TTR >= 65%. A total of 3405 patients were studied (mean age 67.8 years, 41.8% female). Full ABC pathway compliance was evident in 42.7%. For blood pressure control, 41.9% had SBP within target, whereas 35.9% of those on warfarin had TTR within target. The incidence rates of all-cause death/SSE, all-cause death, SSE, major bleeding, intracranial hemorrhage, and heart failure were 5.29, 4.21, 1.51, 2.25, 0.78, and 2.84 per 100 person-years respectively. Adjusted hazard ratios and 95% CI of Atrial Fibrillation Better Care pathway compliance for all-cause death/SSE, all-cause death, and heart failure were 0.76 (0.62-0.94), 0.79 (0.62-0.99), and 0.69 (0.51-0.94), respectively, compared with noncompliance. Patients with Atrial Fibrillation Better Care compliance and SBP within target had a better outcome or TTR within target had better outcomes. ConclusionsIn COOL-AF (Cohort of Antithrombotic Use and Optimal International Normalized Ratio Level in Patients With Non-Valvular Atrial Fibrillation in Thailand), a multicenter nationwide prospective cohort of patients with atrial fibrillation, achieving SBP within target and TTR >= 65% has added value to Atrial Fibrillation Better Care pathway compliance in the reduction of adverse clinical outcomes in patients with atrial fibrillation.
引用
收藏
页数:22
相关论文
共 30 条
  • [1] Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial
    Boehm, Michael
    Brueckmann, Martina
    Eikelboom, John W.
    Ezekowitz, Michael
    Fraessdorf, Mandy
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Mahfoud, Felix
    Schmieder, Roland E.
    Schumacher, Helmut
    Wallentin, Lars
    Yusuf, Salim
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (30) : 2848 - +
  • [2] Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs
    Burdett, Paul
    Lip, Gregory Y. H.
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (02) : 187 - 194
  • [3] Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
    Camm, A. John
    Accetta, Gabriele
    Ambrosio, Giuseppe
    Atar, Dan
    Bassand, Jean-Pierre
    Berge, Eivind
    Cools, Frank
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Haas, Sylvia
    Kayani, Gloria
    Koretsune, Yukihiro
    Mantovani, Lorenzo G.
    Misselwitz, Frank
    Oh, Seil
    Turpie, Alexander G. G.
    Verheugt, Freek W. A.
    Kakkar, Ajay K.
    Lucas Luciardi, Hector
    Gibbs, Harry
    Brodmann, Marianne
    Cools, Frank
    Pereira Barretto, Antonio Carlos
    Connolly, Stuart J.
    Spyropoulos, Alex
    Eikelboom, John
    Corbalan, Ramon
    Hu, Dayi
    Jansky, Petr
    Nielsen, Jorn Dalsgaard
    Ragy, Hany
    Raatikainen, Pekka
    Le Heuzey, Jean-Yves
    Darius, Harald
    Keltai, Matyas
    Kakkar, Sanjay
    Sawhney, Jitendra Pal Singh
    Agnelli, Giancarlo
    Koretsune, Yukihiro
    Sanchez Diaz, Carlos Jerjes
    Ten Cate, Hugo
    Atar, Dan
    Stepinska, Janina
    Panchenko, Elizaveta
    Lim, Toon Wei
    Jacobson, Barry
    Oh, Seil
    Vinolas, Xavier
    Rosenqvist, Marten
    [J]. HEART, 2017, 103 (04) : 307 - 314
  • [4] 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary *
    Chao, Tze-Fan
    Joung, Boyoung
    Takahashi, Yoshihide
    Lim, Toon Wei
    Choi, Eue-Keun
    Chan, Yi-Hsin
    Guo, Yutao
    Sriratanasathavorn, Charn
    Oh, Seil
    Okumura, Ken
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2022, 122 (01) : 20 - 47
  • [5] Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations
    Chao, Tze-Fan
    Guo, Yutao
    [J]. THROMBOSIS AND HAEMOSTASIS, 2020, 120 (03) : 366 - 368
  • [6] Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
    Gorog, Diana A.
    Gue, Ying X.
    Chao, Tze-Fan
    Fauchier, Laurent
    Ferreiro, Jose Luis
    Huber, Kurt
    Konstantinidis, Stavros V.
    Lane, Deirdre A.
    Marin, Francisco
    Oldgren, Jonas
    Potpara, Tatjana
    Roldan, Vanessa
    Rubboli, Andrea
    Sibbing, Dirk
    Tse, Hung-Fat
    Vilahur, Gemma
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1625 - 1652
  • [7] Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
    Guo, Yutao
    Lane, Deirdre A.
    Wang, Limin
    Zhang, Hui
    Wang, Hao
    Zhang, Wei
    Wen, Jing
    Xing, Yunli
    Wu, Fang
    Xia, Yunlong
    Liu, Tong
    Wu, Fan
    Liang, Zhaoguang
    Liu, Fan
    Zhao, Yujie
    Li, Rong
    Li, Xin
    Zhang, Lili
    Guo, Jun
    Burnside, Girvan
    Chen, Yundai
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (13) : 1523 - 1534
  • [8] Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry
    Haas, Sylvia
    ten Cate, Hugo
    Accetta, Gabriele
    Angchaisuksiri, Pantep
    Bassand, Jean-Pierre
    Camm, A. John
    Corbalan, Ramon
    Darius, Harald
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Jacobson, Barry
    Kayani, Gloria
    Mantovani, Lorenzo G.
    Misselwitz, Frank
    Pieper, Karen
    Schellong, Sebastian M.
    Stepinska, Janina
    Turpie, Alexander G. G.
    van Eickels, Martin
    Kakkar, Ajay K.
    Lucas Luciardi, Hector
    Gibbs, Harry
    Brodmann, Marianne
    Cools, Frank
    Pereira Barretto, Antonio Carlos
    Connolly, Stuart J.
    Spyropoulos, Alex
    Eikelboom, John
    Hu, Dayi
    Jansky, Petr
    Nielsen, Jorn Dalsgaard
    Ragy, Hany
    Raatikainen, Pekka
    Le Heuzey, Jean-Yves
    Keltai, Matyas
    Kakkar, Sanjay
    Sawhney, Jitendra Pal Singh
    Agnelli, Giancarlo
    Ambrosio, Giuseppe
    Koretsune, Yukihiro
    Sanchez Diaz, Carlos Jerjes
    Atar, Dan
    Panchenko, Elizaveta
    Lim, Toon Wei
    Oh, Seil
    Vinolas, Xavier
    Rosenqvist, Marten
    Steffel, Jan
    Oto, Ali
    [J]. PLOS ONE, 2016, 11 (10):
  • [9] 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards ( Writing Committee to Develop Cardiovascular Endpoints Data Standards)
    Hicks, Karen A.
    Tcheng, James E.
    Bozkurt, Biykem
    Chaitman, Bernard R.
    Cutlip, Donald E.
    Farb, Andrew
    Fonarow, Gregg C.
    Jacobs, Jeffrey P.
    Jaff, Michael R.
    Lichtman, Judith H.
    Limacher, Marian C.
    Mahaffey, Kenneth W.
    Mehran, Roxana
    Nissen, Steven E.
    Smith, Eric E.
    Targum, Shari L.
    Weintraub, William S.
    Bozkurt, Biykem
    Fonarow, Gregg C.
    Hendel, Robert C.
    Jacobs, Jeffrey P.
    Jneid, Hani H.
    Kutcher, Michael A.
    Lichtman, Judith H.
    Smith, Eric E.
    Tcheng, James E.
    Wang, Tracy Y.
    [J]. CIRCULATION, 2015, 132 (04) : 302 - 361
  • [10] Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945